PharmaCielo Revenue and Competitors

Toronto, ON CAN

Location

$25.7M

Total Funding

Cannabis

Industry

Estimated Revenue & Valuation

  • PharmaCielo's estimated annual revenue is currently $44.4M per year.(i)
  • PharmaCielo's estimated revenue per employee is $352,446
  • PharmaCielo's total funding is $25.7M.

Employee Data

  • PharmaCielo has 126 Employees.(i)
  • PharmaCielo grew their employee count by -5% last year.

PharmaCielo's People

NameTitleEmail/Phone
1
Chief Commercial OfficerReveal Email/Phone
2
Practicante universitariaReveal Email/Phone
3
Coordinadora de procesosReveal Email/Phone
4
asistente de producciónReveal Email/Phone
5
Engineering AnalystReveal Email/Phone
6
Analista de ComprasReveal Email/Phone
7
Analista de planeación de operaciones y control de producciónReveal Email/Phone
8
Ingeniero de mantenimientoReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.4M53-59%$9.2MN/A
#2
$149.5M4437%N/AN/A
#3
$153.6M4552%N/AN/A
#4
$10.6M499%N/AN/A
#5
N/A0N/A$7.7MN/A
#6
$3.8M205%N/AN/A
#7
$144.1M4275%N/AN/A
#8
$21.1M78-20%N/AN/A
#9
$568.6M1116-17%$4.5BN/A
#10
$65.6M2213%N/AN/A
Add Company

What Is PharmaCielo?

Nature's choice from Colombia. PharmaCielo Ltd. is the world's largest licensed cannabis producer. We're the first company to hold Colombian licences for unrestricted percentages of tetrahydrocannabinol (THC) and cannabidiol (CBD). Our mission is to become the world's leading supplier of naturally grown and processed, standardized medicinal-grade cannabis oil extracts and related products. PharmaCielo employs a B2B sales and distribution model targeting large channel distributors, finished goods manufacturers, research organizations and pharmaceutical companies. PharmaCielo Ltd. is a global company headquartered in Ontario, Canada, chosen for the country's standards of financial accountability and regulatory oversight. PharmaCielo Colombia Holdings S.A.S., its wholly owned operating subsidiary, is headquartered in Rionegro, Colombia – a country with outstanding economic conditions, a clear legal framework for cannabis licensing and ideal climatic conditions. The company's facility, combined with its contract growers' space, offers access to 110.2 million square feet of open-air greenhouse cultivation capacity. The combination of the two countries – Canada and Colombia – is a winning structure for developing a sustainable international business model capable of capturing a significant share of the rapidly growing medical cannabis industry.

keywords:N/A

$25.7M

Total Funding

126

Number of Employees

$44.4M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

PharmaCielo News

2022-04-06 - Colombian Government Provides Final Commercial ...

PharmaCielo expects to begin exporting dried flower in the second quarter of 2022, with volumes growing through the remainder of the year.

2021-04-07 - PHARMACIELO LTD. PharmaCielo : Announces Closing of Overnight Marketed Equity Offering for Gross Proceeds of $13.5 Million

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ All figures are in Canadian dollars ($) unless otherwise specified TORONTO and RIONEGRO, Colombia, April 7, 2021 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV: PCLO) (OTCQX: PC ...

2019-07-12 - PharmaCielo to Acquire International Cannabis Company Creso Pharma

By combining the strengths of their respective companies, PharmaCielo–the Canadian parent of Colombia’s premier producer of medicinal-grade cannabis extracts –and Creso Pharma Ltd.–a leading global medicinal cannabis company–are forging a global partnership that is poised to lead the industry. ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$31.5M12635%N/A
#2
$34M12615%N/A
#3
$34M1261%N/A
#4
$18.3M126-5%N/A
#5
$18.4M1278%N/A